Norges Bank
MRTX

Norges Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Norges Bank’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-751,604
Closed -$44.2M – 1993
2023
Q4 		$44.2M Buy
751,604
+319,661
+74% +$18M 0.01% 958
2023
Q3 		$18.8M Hold
431,943
– – ﹤0.01% 1256
2023
Q2 		$15.6M Sell
431,943
-225,295
-34% -$9.28M ﹤0.01% 1364
2023
Q1 		$24.4M Buy
657,238
+181,246
+38% +$8.15M 0.01% 1195
2022
Q4 		$21.6M Buy
475,992
+38,362
+9% +$2.48M 0.01% 1225
2022
Q3 		$30.6M Buy
437,630
+23,641
+6% +$1.75M 0.01% 997
2022
Q2 		$27.8M Buy
413,989
+18,265
+5% +$1.16M 0.01% 1078
2022
Q1 		$32.5M Hold
395,724
– – 0.01% 1122
2021
Q4 		$58M Buy
395,724
+40,077
+11% +$6.22M 0.01% 866
2021
Q3 		$62.9M Sell
355,647
-12,315
-3% -$1.98M 0.01% 807
2021
Q2 		$59.4M Sell
367,962
-22,094
-6% -$3.55M 0.01% 872
2021
Q1 		$66.8M Sell
390,056
-56,434
-13% -$11.2M 0.02% 812
2020
Q4 		$98.1M Sell
446,490
-14,070
-3% -$3.04M 0.02% 598
2020
Q3 		$76.5M Buy
460,560
+12,535
+3% +$1.72M 0.02% 646
2020
Q2 		$51.2M Buy
448,025
+58,575
+15% +$5.68M 0.01% 819
2020
Q1 		$29.9M Buy
389,450
+38,234
+11% +$3.43M 0.01% 979
2019
Q4 		$45.3M Buy
351,216
+128,080
+57% +$12.4M 0.01% 987
2019
Q3 		$17.4M Buy
+223,136
New +$20.9M 0.01% 1548

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Norges Bank's MRTX Position: Q1 2024 in Review

Norges Bank sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 751,604 shares — an estimated $44.2M sold.

Norges Bank first reported a position in MRTX in Q3 2019 and held it in 18 quarters. The position peaked at $98.1M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Norges Bank reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Norges Bank sold 751,604 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $44.2M.
  • Norges Bank first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • Norges Bank's Mirati Therapeutics, Inc. Common Stock position peaked at $98.1M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.